Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysis

被引:22
作者
Koch, N
Yahi, N
Colson, P
Fantini, J
Tamalet, C [1 ]
机构
[1] CHRU La Timone, Virol Lab, F-13005 Marseille, France
[2] Fac Sci St Jerome, Lab Biochim & Biol Nutr, CNRS, ESA 6033, F-13013 Marseille, France
关键词
genetic polymorphism; HIV-1 reverse transcriptase; line probe assay;
D O I
10.1016/S0166-0934(99)00030-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The performance of the line probe assay (LIPA) for the detection of mutations conferring resistance to nucleoside inhibitors of HIV-1 reverse transcriptase was evaluated in comparison with sequence analysis. The tests were undertaken on plasma samples from 63 patients (61 receiving combination therapy and 2 without treatment at the time of inclusion). In 27 cases (43%) which included codons 41, 69, 70, 74, 184 and 215, the sequence of the RT gene was distinct from the hybridization probes used in LIPA. Correspondingly, LIPA gave uninterpretable results in 15, 30 and 41% of cases for codons 184, 215 and 41, respectively. Overall, the concordance between LIPA and sequence analysis varied from 52% (codons 41 and 215) to 85% (codon 70). These data show that the polymorphism of the nucleotide sequence near resistance-associated codons is a major shortcoming of LIPA. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 17 条
  • [1] HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY
    COFFIN, JM
    [J]. SCIENCE, 1995, 267 (5197) : 483 - 489
  • [2] Line probe assay for detection of human immunodeficiency virus type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase:: Comparison with sequence analysis
    Descamps, D
    Calvez, V
    Collin, G
    Cécille, A
    Apetrei, C
    Damond, F
    Katlama, C
    Matheron, S
    Huraux, JM
    Brun-Vézinet, F
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (07) : 2143 - 2145
  • [3] Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples
    Günthard, HF
    Wong, JK
    Ignacio, CC
    Havlir, DV
    Richman, DD
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (10) : 869 - 876
  • [4] Antiretroviral drug resistance testing in adults with HIV infection -: Implications for clinical management
    Hirsch, MS
    Conway, B
    D'Aquila, RT
    Johnson, VA
    Brun-Vézinet, F
    Clotet, B
    Demeter, LM
    Hammer, SM
    Jacobsen, DM
    Kuritzkes, DR
    Loveday, C
    Mellors, JW
    Vella, S
    Richman, DD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (24): : 1984 - 1991
  • [5] A MICROTITRE FORMAT POINT MUTATION ASSAY - APPLICATION TO THE DETECTION OF DRUG-RESISTANCE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTED PATIENTS TREATED WITH ZIDOVUDINE
    KAYE, S
    LOVEDAY, C
    TEDDER, RS
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1992, 37 (04) : 241 - 246
  • [6] 5TH MUTATION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CONTRIBUTES TO THE DEVELOPMENT OF HIGH-LEVEL RESISTANCE TO ZIDOVUDINE
    KELLAM, P
    BOUCHER, CAB
    LARDER, BA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (05) : 1934 - 1938
  • [7] A MUTATION IN HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE AND DECLINE IN LYMPHOCYTE-CD4 NUMBERS IN LONG-TERM ZIDOVUDINE RECIPIENTS
    KOZAL, MJ
    SHAFER, RW
    WINTERS, MA
    KATZENSTEIN, DA
    MERIGAN, TC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03) : 526 - 532
  • [8] LARDER B, 1996, ANTIVIRAL DRUG RESIS, P169
  • [9] POTENTIAL MECHANISM FOR SUSTAINED ANTIRETROVIRAL EFFICACY OF AZT-3TC COMBINATION THERAPY
    LARDER, BA
    KEMP, SD
    HARRIGAN, PR
    [J]. SCIENCE, 1995, 269 (5224) : 696 - 699
  • [10] ZIDOVUDINE RESISTANCE PREDICTED BY DIRECT DETECTION OF MUTATIONS IN DNA FROM HIV-INFECTED LYMPHOCYTES
    LARDER, BA
    KELLAM, P
    KEMP, SD
    [J]. AIDS, 1991, 5 (02) : 137 - 144